These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
542 related articles for article (PubMed ID: 7031546)
21. [Transmission of drugs from the mother to the fetus]. Schneider H Gynakologe; 1982 Sep; 15(3):122-35. PubMed ID: 7173721 [No Abstract] [Full Text] [Related]
22. Transmission of drugs by the placenta and the breasts. Smithells RW; Morgan DM Practitioner; 1970 Jan; 204(219):14-9. PubMed ID: 5411150 [No Abstract] [Full Text] [Related]
23. The placenta and placental transfer of drugs at term. Abouleish E Pa Med; 1975 May; 78(5):56-62, 68-74. PubMed ID: 1093102 [No Abstract] [Full Text] [Related]
24. Disposition of valproic acid in maternal, fetal, and newborn sheep. I: placental transfer, plasma protein binding, and clearance. Kumar S; Wong H; Yeung SA; Riggs KW; Abbott FS; Rurak DW Drug Metab Dispos; 2000 Jul; 28(7):845-56. PubMed ID: 10859159 [TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics of inhibitors of prostaglandin synthesis in the perinatal period. Berman W; Friedman Z; Vidyasagar D Semin Perinatol; 1980 Jan; 4(1):67-72. PubMed ID: 6770469 [No Abstract] [Full Text] [Related]
27. [Pre- and perinatal use of drugs]. Ankermann H Z Arztl Fortbild (Jena); 1970 Nov; 64(22):1125-9. PubMed ID: 5505103 [No Abstract] [Full Text] [Related]
28. Metabolic capabilities of the human fetus: drug biotransformation. Juchau MR Addict Dis; 1975; 2(1-2):37-43. PubMed ID: 1163372 [No Abstract] [Full Text] [Related]
29. [Role of pharmacokinetics in realizing the embryotoxic action of drugs]. Smol'nikova NM; Boĭko SS; Liubimov BI Farmakol Toksikol; 1986; 49(2):106-11. PubMed ID: 3519275 [No Abstract] [Full Text] [Related]
30. Pharmacokinetics in the ovine maternal-fetal unit. Szeto HH Annu Rev Pharmacol Toxicol; 1982; 22():221-43. PubMed ID: 7044285 [No Abstract] [Full Text] [Related]
31. [Role of maternal and fetal plasma proteins in transplacental transport of drugs]. Bender KI; Lutsevich NF; Lutsevich AN; Kupchikov VV Farmakol Toksikol; 1989; 52(4):100-10. PubMed ID: 2680590 [TBL] [Abstract][Full Text] [Related]
32. The diaplacental kinetics of drugs. Kuemmerle HP Int J Clin Pharmacol; 1974 Jun; 9(4):298-304. PubMed ID: 4418872 [No Abstract] [Full Text] [Related]
33. Drugs and the fetomaternal unit. Brock-Utne JG; Downing JW; Mankowitz E S Afr Med J; 1980 Aug; 58(9):366-9. PubMed ID: 7404257 [TBL] [Abstract][Full Text] [Related]
35. [Dosage and adverse effect problems in pregnancy]. Kuemmerle HP Int Z Klin Pharmakol Ther Toxikol; 1971 Dec; 5(3):356-9. PubMed ID: 5148893 [No Abstract] [Full Text] [Related]
36. Pharmacokinetic considerations in the maternal-placental-fetal unit. Juchau MR; Faustman-Watts E Clin Obstet Gynecol; 1983 Jun; 26(2):379-90. PubMed ID: 6851290 [No Abstract] [Full Text] [Related]
37. Selenium kinetics, placental transfer, and neonatal exposure in cynomolgus macaques (Macaca fascicularis). Hawkes WC; Willhite CC; Omaye ST; Cox DN; Choy WN; Tarantal AF Teratology; 1994 Aug; 50(2):148-59. PubMed ID: 7801302 [TBL] [Abstract][Full Text] [Related]
38. Designing pregnancy centered medications: drugs which do not cross the human placenta. Gedeon C; Koren G Placenta; 2006 Aug; 27(8):861-8. PubMed ID: 16313957 [TBL] [Abstract][Full Text] [Related]
39. Pharmacology of the neonate. Currin MR S Afr Med J; 1979 Jul; 56(3):101-5. PubMed ID: 386526 [TBL] [Abstract][Full Text] [Related]
40. Localization and metabolism of drugs in the fetus. Waddell WJ Fed Proc; 1972; 31(1):52-61. PubMed ID: 4400374 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]